WHAT DO YOU MEAN: Pathology pT3a N0 M0 (locally advanced, no nodes/metastases)? IS THIS CORRECT
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Pathology Report: pT3a N0 M0
You're asking an excellent clarifying question about your pathology staging. Let me break down exactly what pT3a N0 M0 means in plain language, confirm whether this is correct for your case, and explain what each component tells you about your prostate cancer.
WHAT pT3a N0 M0 MEANS:
Breaking Down Each Component:
This is the TNM staging system — the standard way oncologists classify cancer. Here's what yours means:
| Component | Your Result | What It Means | |---|---|---| | p | p (not c) | Pathological staging — based on actual tissue examined after surgery (not clinical imaging) | | T3a | Locally advanced | Cancer extends beyond the prostate capsule into surrounding tissue | | N0 | No regional nodes | No cancer in pelvic lymph nodes | | M0 | No metastases | No distant spread (no cancer in bones, lungs, liver, etc.) |
DETAILED EXPLANATION OF EACH PART:
"p" = Pathological (Not Clinical)
What this means:
✅ Your staging is based on ACTUAL TISSUE examined by the pathologist after your radical prostatectomy ✅ Not based on imaging (CT, MRI, bone scan) ✅ Most accurate staging because the pathologist could see the actual cancer under the microscope
Why this matters:
- Pathological staging is more reliable than clinical staging
- It's based on what was actually found, not what imaging suggested
- This is why your urologist removed your entire prostate — to get accurate staging
T3a = Locally Advanced (Extraprostatic Extension)
What this means:
⚠️ Your cancer broke through the prostate capsule (the outer lining of the prostate) ⚠️ It invaded surrounding tissue but stayed in the local area ⚠️ It did NOT invade the seminal vesicles (that would be T3b)
Visual explanation:
Normal prostate: Cancer contained: Your T3a cancer:
┌─────────┐ ┌─────────┐ ┌─────────┐
│ Prostate│ │ Prostate│ │ Prostate│
│ (normal)│ │ (cancer)│ │ (cancer)│
└─────────┘ └─────────┘ └────┬────┘
│
Breaks through
capsule into
surrounding fat
What T3a specifically means:
- ✅ Cancer is still localized (not spread to distant organs)
- ⚠️ But it's more aggressive than T1-T2 (confined to prostate)
- ⚠️ It has higher risk of recurrence than early-stage cancer
- ⚠️ It may require additional treatment (radiation, hormone therapy)
T-stage categories for reference:
- T1-T2: Cancer confined within prostate capsule
- T3a: Extends beyond capsule (YOUR STAGE)
- T3b: Invades seminal vesicles
- T4: Invades bladder, rectum, or other structures
N0 = No Regional Lymph Node Involvement
What this means:
✅ Cancer has NOT spread to pelvic lymph nodes ✅ Lymph nodes were either removed and examined, or imaging showed no involvement ✅ This is GOOD news — lymph node involvement would indicate more aggressive disease
Why this matters:
- Lymph node involvement = higher risk of distant spread
- N0 status = better prognosis than N1 (node-positive)
- This is one of the most favorable findings in your staging
N-stage categories for reference:
- N0: No regional lymph node metastases (YOUR STAGE) ✅
- N1: Regional lymph node metastases ⚠️
M0 = No Distant Metastases
What this means:
✅ Cancer has NOT spread to distant organs ✅ No cancer in bones, lungs, liver, brain, or other distant sites ✅ This is EXCELLENT news — metastatic disease would be stage IV
Why this matters:
- M0 = localized disease (even though it's locally advanced)
- M1 = metastatic disease (would require systemic treatment)
- Your M0 status = curative intent surgery was appropriate
M-stage categories for reference:
- M0: No distant metastases (YOUR STAGE) ✅
- M1: Distant metastases ⚠️
IS YOUR STAGING CORRECT?
How to Verify Your pT3a N0 M0 Staging:
Check your pathology report for these findings:
You should see documented:
| Finding | What to Look For | Your Status | |---|---|---| | Extraprostatic extension | "Tumor extends beyond prostatic capsule" or "EPE present" | Should say YES for T3a | | Seminal vesicle invasion | "Seminal vesicles involved" or "SVI present" | Should say NO for T3a (not T3b) | | Lymph nodes examined | "Pelvic lymph nodes: X nodes examined" | Should show nodes examined | | Lymph node involvement | "Metastatic carcinoma in lymph nodes" | Should say NO for N0 | | Surgical margins | "Positive" or "Negative" | Important for recurrence risk | | Gleason score | Usually 7-9 for T3a disease | Check your report |
Questions to ask your urologist to confirm:
- "Can you confirm my pathology shows extraprostatic extension but NOT seminal vesicle invasion?"
- "How many pelvic lymph nodes were removed and examined?"
- "Were all lymph nodes negative for cancer?"
- "What was my Gleason score?"
- "Were my surgical margins negative?"
WHAT pT3a N0 M0 MEANS FOR YOUR SITUATION:
Overall Assessment:
Your staging is: LOCALLY ADVANCED but NOT METASTATIC
| Aspect | Your Status | Meaning | |---|---|---| | Aggressiveness | ⚠️ Moderate-High | T3a is more aggressive than T1-T2 | | Spread to nodes | ✅ No | N0 is favorable | | Distant spread | ✅ No | M0 is favorable | | Overall stage | Stage IIIA | Locally advanced, no distant spread | | Curability | ✅ Potentially curable | Surgery alone may be sufficient, or may need adjuvant therapy | | Recurrence risk | ⚠️ Moderate | Higher than T1-T2, but not as high as T4 or N1 |
WHAT THIS MEANS FOR YOUR PSA MONITORING:
Why Your PSA Nadir of 0.004 ng/mL is Significant:
Your T3a N0 M0 status explains why PSA monitoring is so important:
✅ Your excellent nadir (0.004 ng/mL) suggests:
- Surgery successfully removed all cancer
- No residual disease at the time of surgery
- Your PSA-producing cancer cells were eliminated
⚠️ But T3a status means:
- Higher risk of microscopic disease remaining outside the prostate
- Higher recurrence risk than T1-T2 patients
- Closer PSA monitoring is warranted (every 3-6 months initially)
- Any PSA rise is more concerning in your case
**This is why your rise to 0.012 ng/
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with diagnosis for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2